Asthma Trial, Recruiting NCT05844891 Sponsor: University of Rochester Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05844891
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child has been diagnosed with asthma by a doctor, confirmed through medical records and/or a parent or caregiver's report.
  • The child is currently at the emergency department for a sudden worsening of asthma that requires treatment with quick-relief (rescue) medication.
  • The child has ongoing or poorly controlled asthma, meaning at least one of the following applies in the past month: asthma symptoms on more than 2 days per week; use of rescue medication on more than 2 days per week; nighttime asthma symptoms on more than 2 nights per month (or more than 1–2 nights per month for children aged 3–4); or at least one other asthma episode in the past year (or past 6 months for children aged 3–4) that required steroid treatment.
  • The child is aged 3 to 12 years old.
  • The child and their caregiver live in the greater Rochester, NY area, including Monroe, Wayne, Ontario, Livingston, Genesee, or Orleans Counties.
  • The child's emergency triage score falls between 2 and 5 on the Emergency Severity Index scale (scores of 1 indicate the most critical cases).

Who may not be able to join:

  • Neither the parent/caregiver nor the child is able to speak and understand English. (Note: low reading ability or low health literacy is not an exclusion, as surveys will be delivered verbally and materials are designed for low-literacy audiences.)
  • There is no access to a working phone — at home or nearby — for follow-up contact. (Note: if a video-visit-capable device is not available at home, the trial site may be able to provide one.)
  • The child has another significant medical condition — such as cystic fibrosis, a congenital heart condition, or another chronic lung disease — that could affect the measurement of asthma-related outcomes.
  • The child is in foster care or another situation where a legal guardian is not available to provide consent.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of asthma-related hospitalizations and emergency department visits after discharge

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov